From: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma
Characteristics
N(%)
238 cases
 Age
  Median
59
  Range
44–78
 Sex
  Male
204(85.7)
  Female
34(14.3)
818 cases
53
430(52.6)
388(47.4)